[1]ACSCatalysis,2018,vol.8,#1,p.738-741
[1]Patent:US2006/52378,2006,A1,.Locationinpatent:Page/Pagecolumn144
[2]BioorganicandMedicinalChemistryLetters,2016,vol.26,#10,p.2539-2543
[3]JournaloftheAmericanChemicalSociety,1944,vol.66,p.1875,1879
[4]EuropeanJournalofMedicinalChemistry,2014,vol.76,p.314-331
[5]BioorganicandMedicinalChemistry,2015,vol.23,#5,p.911-923
[6]BioorganicandMedicinalChemistryLetters,2017,vol.27,#22,p.5053-5059
[1]BioorganicandMedicinalChemistry,2007,vol.15,#1,p.575-585
[2]Tetrahedron,2004,vol.60,#3,p.569-575
[3]OrganicLetters,2011,vol.13,#4,p.600-603
[4]BioorganicandMedicinalChemistryLetters,2012,vol.22,#23,p.7219-7222
[1]ArchivderPharmazie(Weinheim,Germany),1942,vol.280,p.213,224
[2]OrganicLetters,2011,vol.13,#4,p.600-603
[3]BioorganicandMedicinalChemistryLetters,2012,vol.22,#23,p.7219-7222
[1]AnalesdeslaAsociacionQuimicaArgentina,1945,vol.33,p.167,171
[1]JournalofOrganicChemistry,1972,vol.37,p.2387-2391
[1]ArchivderPharmazie,1987,vol.320,p.647-654
[1]ArchivderPharmazie,1987,vol.320,p.647-654
[1]JournalofMedicinalChemistry,2007,vol.50,p.4250-4254
Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
Journal: Bioorganic & medicinal chemistry letters 20101101